gs-9411
Small moleculeexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2008 (NCT00800579)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
SCNN1A antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gs-9411
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01025713 | Phase 1 | Dec 1, 2009 | Gilead Sciences, The Alfred Hospital |
| NCT00999531 | Phase 1 | Oct 1, 2009 | Gilead Sciences, Nucleus Network Ltd |
| NCT00951522 | Phase 1 | Sep 1, 2009 | Gilead Sciences, Nucleus Network Ltd |
| NCT00800579 | Phase 1 | Nov 1, 2008 | Gilead Sciences, Nucleus Network Ltd |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Gilead Sciences | For profit | 4 | 4 | 1 | 2008 |
| Nucleus Network Ltd | For profit | 3 | 0 | 1 | 2008 |
| The Alfred Hospital | Academic/Hospital | 1 | 0 | 1 | 2009 |
3 organizations
Page 1 / 1